Moreover, BayK8644-induced tumor control was mediated by CD8+ T cells as it increased CD8+ T cell-dependent tumor cytotoxicity in vivo (Figure 6I), and depletion of CD8+ T cells completely abolished the antitumor effect of this inhibitor (Figures 6J and S8F). This evidence concerns the gene CD8A and neoplasm.